In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.
Many patients with chronic hepatitis B virus (HBV) are experiencing improved outcomes thanks to the advent of antiviral therapies. However, not all patients with chronic HBV have been considered candidates...
